An Overview of Sarcopenia: Focusing on Nutritional Treatment Approaches.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search methodology or quantitative synthesis
PubMed 40218995 · doi:10.3390/nu17071237
What was done
This narrative overview synthesized evidence on the classification, mechanisms, and nutritional management strategies for primary (age-related) and secondary sarcopenia, as well as the role of concurrent resistance exercise.
What was found
The abstract reports that primary sarcopenia begins after the fourth decade of life, with muscle loss occurring at approximately 8% per decade until age 70, increasing to 15% per decade thereafter. It identifies key nutritional strategies, including adequate caloric and protein intake, whey protein, omega-3 fatty acids, branched-chain amino acids, β-hydroxy-β-methylbutyrate (HMB), vitamin D, and medical foods, noting that resistance training acts synergistically with nutrition to promote muscle protein synthesis. No comparative trial outcome numbers or effect sizes are reported in the abstract.
Why it matters
It provides a broad overview of dietary strategies and supplements intended to combat progressive muscle mass and strength loss in aging and chronic illness.
Limits
The abstract describes a broad narrative review rather than a systematic review or meta-analysis. It lacks formal study selection criteria, risk-of-bias assessments, and quantitative effect estimates.
Cited by
- supports By a person's 60s and 70s, up to 15% of muscle mass can be lost per decade without intervention.